EMJ GOLD

The first patient has received a personalised lung cancer vaccine in a world-first clinical trial for advanced non-small cell lung cancer.

Sanofi raises its full-year 2026 guidance following strong Q2 results, with dupilumab surpassing €5bn in quarterly sales for the first time.

From China’s biotech licensing boom to the UK’s first GLP-1 weight-loss pill, explore the biggest pharma and life sciences stories from July.

A food poisoning outbreak linked to lettuce is driving concerns among consumers.

AstraZeneca maintained revenue growth in the second quarter of 2026 as demand for its oncology medicines grew.

A phase 3 trial of ravulizumab fell short in adult HSCT-TMA patients, while paediatric results held more promise.

Trump’s generic drug manufacturing tariff plan outlined future import duties and raised supply chain concerns. Read more.

It found that patients taking weight loss drugs had a modestly higher risk of developing non-scarring alopecia.